Advanced Unresectable Solid Tumors
3 clinical trials · Condition
◉ Watch Advanced Unresectable Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China (NCT04894825) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2021-06-11 |
| Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors (NCT02508441) | Andes Biotechnologies | 2015-12-08 |
| A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors (NCT02428712) | Fore Biotherapeutics | 2015-04-01 |
Track Advanced Unresectable Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.